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Highlights 
 Phthalates’ side-chain structures associated with hydrolysis metabolism.  
 Phthalate metabolites appear to exert different effects at an endocrine level compared to 
parent compounds. 
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 Hydrolysis metabolism reversed DBP-induced anti-androgenic effects into the 
androgenic effects. 
 
 
Abstract 
Although it is well acknowledged that the anti-androgenic phthalate diesters can be 
readily hydrolysed into their monoester counterparts, their metabolites’ toxicology 
remains obscure. Herein, we tested the hypothesis that hydrolysis of one of the two 
ester bonds can mediate phthalate diesters’ potential endocrine effects in MLTC-1 
Leydig cells, in line with their ability to disrupt androgen secretion in humans. Five 
diesters (DMP, DEP, DBP, DBzP and DEHP) and five monoesters (MMP, MEP, MBP, 
MBzP and MEHP) phthalates as mixtures or individually were applied to cell lines to 
investigate differences in phthalates’ hydrolysis associated with varying side-chain 
structures and steroidogenic effects. Short-chain diesters DMP, DEP and DBP are 
more readily hydrolysed compared to the long-chain DEHP, while aromatic alkyl 
chain DBzP cannot be metabolized completely in vitro. When the hydrolysis 
processes are interrupted, the diester phthalates’ steroidogenic effects can be 
influenced via regulating related steroidogenic pathway genes. With 10 to 100 μM 
treatment exposures, androgenic effects were observed only with DMP or DEP but 
not for MMP or MEP; while the phthalate diesters DBP, DBzP or DEHP generally 
exhibited more complex steroidogenic effects than their corresponding monoester 
counterparts (i.e., biphasic androgen and anti-androgen effects for diesters but 
monotonic androgen effects for monoesters were observed). DBP elicited 
hydrolysis-related steroidogenic modulation, in which the anti-androgenic effects of 
diester DBP reversed into the androgenic effects of monoester MBP at 100 μM. 
Phthalate metabolites appear to exert different effects at an endocrine level compared 
to parent compounds, and deeper insights into how the hydrolytic process is related to 
this alternating toxicity would improve our understanding of a risk assessment for 
these widespread contaminants in male reproduction. 
 
 
Keywords: Androgen, Hydrolysis metabolism, MLTC-1 cells, Phthalate, 
Steroidogenesis 
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1. Introduction 
Phthalates are diesters of 1, 2-benzenedicarboxylic acid (o-phthalic acid) and 
their molecular structures contain one benzene ring and two esters. The two 
hydrocarbon chains with various structures confer phthalates with their various 
physical properties; the chains are straight or branching alkanols with increasing 
carbons from methanol to tridecanol (Fernández et al. 2012; Park et al. 2014). These 
unique physicochemical properties mean that phthalates are ideally suited for 
applications in industrial and consumer products, including plasticizers, food 
packaging materials, toys, personal care products and medical devices (Shea 2003; 
Mankidy et al. 2013). Phthalates are not chemically bound to products, and hence, 
they can easily migrate from these matrices into the environment and human body via 
a variety of routes (Blanchard et al. 2014; Swan 2008). Generally, humans are 
exposed to phthalates via oral, inhalation, dermal and intravenous routes (Hauser and 
Calafat 2005). 
As endocrine disrupting chemicals, phthalates are generally thought to be 
anti-androgens and are suspected to generate adverse effects on the male reproductive 
system (Moore et al. 2001; Mankidy et al. 2013). Phthalates’ alkanol moieties are 
associated with their anti-androgen potency. In foetal male rat models, phthalates 
exhibit a structure-specific inhibition to testosterone production in testis: diphenyl 
ortho-phthalate (DPP) is more potent than butyl benzyl phthalate (BBP), dibutyl 
phthalate (DBP) and diisobutyl phthalate (DIBP), while short-chain diethyl phthalate 
(DEP) and dimethyl phthalate (DMP) have no observable effects (Clewell et al. 2010; 
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Howdeshell et al. 2008). 
Post-oral uptake, lipophilic phthalate diesters can be initially transformed via 
phase I hydrolysis. In mammals, phthalate diesters are rapidly hydrolysed by lipases 
or esterases to generate phthalate monoesters; subsequently, some median to long 
side-chain monoesters will be further metabolized by cytochrome P450s (CYPs) via 
β-oxidation. Then these metabolites are phase II conjugated before they are excreted 
via the urine (Calafat et al. 2006; Frederiksen et al. 2007). Esterases involved in 
phthalates’ phase I hydrolysis can be found in the small intestine, colon, kidney, liver, 
heart brain and testis (Harris et al. 2016; Xu et al. 2002). 
Although not always the case, metabolism generally protects the organism 
against xenobiotic-induced toxicity. A recent study indicates that phthalate diesters are 
more toxic than monoesters (Xu et al. 2016), while another study suggests that 
phthalates in their diester or glucuronidated metabolic forms are non-toxic (Stein et al. 
2013), whilst another suggests that there is no difference in toxicity profile between 
monoester and glucuronidated metabolites (Katsikantami et al. 2016). Therefore, 
although phthalates’ metabolism has been widely characterized, the association of 
these metabolic processes and endocrine effect alterations remains under debate. 
Testicular Leydig cells are the primary source of steroid hormone in the male, 
and steroid hormone production starts with cholesterol, which is converted into one of 
the important intermediates of androstenedione (ASD) before production of the 
end-product sex hormone, testosterone (Bochud et al. 2018). Moreover, a previous 
study confirmed that in vitro testicular cells can hydrolyse phthalate diesters into 
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monoesters forms (Harris et al., 2016); mouse Leydig tumour cells (MLTC-1) are a 
useful tool in the assessment of effects on steroidogenesis (Svechnikov et al. 2016). 
Herein, phthalate hydrolysis interference experiments were employed to examine 
the possible associations of hydrolytic processes with steroidogenesis, and the 
phthalates side-chain structures associated hydrolytic metabolism in MLTC-1 Leydig 
cells. The aim of this study is to elucidate the association between phthalate 
hydrolysis and their ability to induce endocrine disrupting alterations. The results will 
improve our understanding of the hydrolytic processes related to toxic changes of 
these widespread male reproductive contaminants. 
 
2. Materials and methods 
2.1. Chemicals and reagents 
The following phthalate diesters: dimethyl phthalate (DMP), diethyl phthalate 
(DEP), dibutyl phthalate (DBP), di-(2-ethylhexyl) phthalate (DEHP) and dibenzyl 
phthalate (DBzP) were purchased from TCI (Tokyo Chemical Industry Europe, 
Belgium, Brussels). The C13- and C12-phthalate monoesters: monomethyl phthalate 
(MMP), monoethyl phthalate (MEP), monobutyl phthalate (MBP), mono-2-ethylhexyl 
phthalate (MEHP) and monobenzyl phthalate (MBzP) were purchased from CIL 
(Cambridge Isotope Laboratory Ins, USA). The selected phthalates’ structures are 
shown in Table S1 [see Supplementary Information (SI)]. Dimethyl sulfoxide 
(DMSO), esterase, Escherichia coli ß-glucuronididase and constitutive androstane 
receptor (CAR) inhibitor 
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1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK 
11195) were purchased from Sigma-Aldrich Chemical Co. (St. Louis, Mo. USA). 
Human chorionic gonadotrophin (hCG) was obtained from PROSPECT (Ness-Ziona, 
Israel). The steroid hormone standards of androstenedione (ASD), testosterone and 
17-OH progesterone (17-OHP) were purchased from Dr. Ehrenstorfer GmbH 
(Augsburg, Germany). The isotopes D3-testosterone and D3-17-OHP were purchased 
from Cerilliant (Promochem, Wesel, Germany). Oasis HLB solid-phase extraction 
(SPE) cartridges (60 mg, 3 mL) were purchased from Waters Corporation (Milford, 
MA). The Carboxylesterase (Ces) Activity Assay Kit was obtained from Nanjing 
Jiancheng Bioengineering Institute (Nanjing, China). 
2.2. Cell culture and phthalate treatment 
The MLTC-1 cell line was obtained from the Cell Institute of Shanghai 
(Shanghai, China) and cultured in RPMI-1640 medium (Gibco BRL, Grand Island, 
NY) supplemented with 100 unit/mL penicillin, 100 unit/mL streptomycin and 10% 
(v/v) foetal bovine serum (Hyclone, USA). The cells were grown at 37oC with 5% 
CO2 in a humidified incubator (SANYO, Japan). The MLTC-1 cells were seeded in 
10-cm petri dishes and cultured for 48 h prior to further treatment. Phthalates were 
dissolved in DMSO. Cell viability was evaluated by the MTT proliferation assay (see 
SI Figure S1) to ensure that non-cytotoxic concentrations were employed for the 
following phthalates exposure experiments. 
The first set of experiments was designed to assess the hydrolysis metabolism 
profiles of phthalate diesters and the different endocrine disrupting effects between 
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phthalate diesters and monoesters mixture exposure. Referencing the MTT results and 
previous studies reporting the general Chinese male population maximum exposure 
levels (0.03 to 0.48 μM) (Tian et al., 2018) and the general German male population 
(0.32 to 3.70 μM) (Koch et al., 2003), MLTC-1 cells were exposed to 0.1% (v/v) 
DMSO vehicle control, four levels of equimolar diester phthalate mixtures (i.e., 0.1, 1, 
10 or 100 μM of DMP, DEP, DBP, DBzP and DEHP in mixtures) and four levels of 
equimolar monoester phthalate mixtures (i.e., 0.1, 1, 10 or 100 μM of MMP, MEP, 
MBP, MBzP and MEHP in mixtures). 
The second set of experiments was designed to assess how the endocrine 
disrupting effect of high-dose phthalate diesters are modified when facilitating 
diesters hydrolysis by the extracellular esterase. MLTC-1 cells were exposed to 
DMSO 0.1% (v/v) vehicle control, 100 μM of equimolar phthalate diesters mixture 
(100 μM of DMP, DEP, DBP, DBzP or DEHP in mixtures), 100 μM of equimolar 
phthalate monoesters mixture (100 μM of MMP, MEP, MBP, MBzP or MEHP in 
mixtures) and 100 μM of phthalate diesters mixture plus carboxylic ester hydrolase 
(15 units; Sigma-Aldrich, USA) to facilitate phthalate diesters hydrolysis. 
The third set of experiments was designed to assess how the endocrine disrupting 
effect of low-dose phthalate diesters are modified when diesters hydrolysis is 
inhibited by the intracellular carboxylesterase inhibitor. Carboxylesterase (Ces2a) 
gene expression and enzyme activity can be inhibited when the activity of CAR is 
inhibited by the antagonist PK 11195. In this set of experiments, MLTC-1 cells were 
exposed to 0.1% (v/v) DMSO vehicle control, PK 11195 (5 μM), 10 μM of equimolar 
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phthalate diesters mixture (10 μM of DMP, DEP, DBP, DBzP or DEHP in mixture), 
and 10 μM of equimolar phthalate diesters mixture plus PK 11195 (5 μM). 
The last set of experiments was designed to assess the different endocrine 
disrupting effects between individual exposures of phthalate diesters and monoesters. 
MLTC-1 cells were exposed to 0.1% (v/v) DMSO vehicle control, the individual 
phthalate diesters (10 or 100 μM of DMP, DEP, DBP, DBzP or DEHP, respectively) 
and the individual monoesters (1 or 10 μM of MMP, MEP, MBP, MBzP or MEHP, 
respectively). 
After 48-h exposure, the culture medium was collected for phthalate metabolites 
analysis, and the cells were washed with 4 ml PBS and serum-free medium towards 
assessing steroidogenic functions. The cells were stimulated with hCG (0.1 U/ml) for 
4 h in serum-free medium with 0.1% BSA. The medium was collected for 17-OHP, 
ASD and testosterone determination, and cells were either prepared for RNA 
extraction or gene expression analysis or for carboxylesterase activity determination. 
2.3. RNA extraction and real-time RT-PCR analysis 
To determine mRNA expression alterations, a quantitative real-time PCR assay 
was performed. Total RNA was extracted from cells using a RNA extraction kit 
(Promega, USA) following the manufacturer’s protocol. Extracted RNA samples were 
stored at -80oC for subsequent analysis. The NanoDrop spectrophotometer (NanoDrop 
Technologies Inc., USA) was used to measure RNA concentration and purity. Reverse 
transcription of cDNA synthesis was performed using oligo dT primer, in which 1 μg 
total RNA using PrimeScript® RT reagent Kit together with gDNA Eraser cDNA 
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synthesis Kits (Takara, Japan) were applied. Real-time PCR was carried in a final 
volume of 20 μL and performed in triplicate using SYBR Green Master Mix reagents 
(Roche, USA) in a LC 480 system (Roche Applied Science, Germany) according to 
the manufacturer’s protocol. Primer sets and product sizes used for amplification PCR 
analysis are shown as Table S2 (see SI). The conditions for quantitative PCR were as 
follows: 95oC for 10 min followed by 40 cycles at 95oC for 15 s, and 60oC for 30 s. 
Gene expression levels were normalized to GAPDH expression levels. Three 
replicates of quantitative PCR were performed for each sample. Three replicates for 
each dose of phthalates exposure were performed. The fold-changes of the tested 
genes were analysed by the 2-Ct method. 
2.4. Carboxylesterase activity assay 
Carboxylesterase activity was assessed using a commercial kit from the Nanjing 
Jiancheng Bioengineering Institute (Nanjing, China). In brief, spectrophotometric 
recordings of carboxylesterase activity measured in a previous study (Zhu and He 
2000) with the modification of using α-naphthyl acetate (α-NA) as substrate were 
used as standards. Concentration changes of the substrate’s hydrolysis product were 
measured at λ = 450 nm on a SpectraMAX190 microplate reader and quantified by 
SOFTmax software (Molecular Devices, Sunnyvale, CA). Non-enzymatic controls 
(0.01 M Tris-HCl buffer, pH 7.4) were also assayed. Three biological and three 
technical replicates were performed. For estimation of protein, the BCA protein assay 
kit (Thermo Fisher Scientific, USA) was employed. The specific activity of 
carboxylesterase is defined as the increased absorption value per minute per milligram 
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of cell protein, and the activity of carboxylesterase was expressed as units of enzyme 
activity of carboxylesterase per milligram protein (U/mg protein). 
2.5. Determination of phthalates metabolites and steroid hormones in cell culture 
medium 
Phthalate metabolites in cell culture medium were detected using a published 
method for isotope dilution liquid chromatography-electrospray-ionization coupled 
with tandem mass spectrometry (LC-ESI-MS/MS; Applied Biosystems/MDS SCIEX, 
Singapore). Five hydrolysed phthalate metabolites (i.e., MMP, MEP, MBP, MBzP 
and MEHP) were determined. Briefly, phthalate metabolites in cell medium were 
initially de-conjugated using Escherichia coli β-glucuronididase, then purified through 
a SPE cartridge, and finally analysed by an isotope dilution method using 
LC-ESI-MS/MS. Two method blanks, two quality control samples (sample spiked 
with standards) and two sets of standards were also run together with the unknown 
samples in each analytical batch. The contents of the total species (i.e., the conjugated 
monoester phthalates plus their free forms) were calculated by modifying our 
published method (Liu et al. 2012; Tian et al. 2018). 
The steroid hormones 17-OHP, ASD and testosterone were detected in the cell 
culture medium by LC-ESI-MS/MS (Tian et al. 2018). In brief, each sample of 1 mL 
medium was diluted with 3 mL of ammonium acetate buffer (1 mol/L), and 20 μL of 
100 ng/mL D3-testosterone and D3-17-OHP were added as internal standard (ASD 
was semi-quantified). Then the diluted samples were extracted by adding 3 mL ethyl 
acetate and vortexed vigorously for 15 sec in a glass tube. The liquid-liquid extraction 
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was repeated 3 times. Then the subsequent phase separation was achieved by 
centrifugation at 1500 rpm for 10 min. The organic phase was transferred into another 
glass tube with a Pasteur pipette. The three times extract was combined and washed 
with 5 mL water, then the combined extracts were evaporated under a gentle stream 
of nitrogen gas at 40oC. The residual was reconstituted with 200 μL of 
methanol/water (50:50, v:v) by vortexing vigorously for 15 sec and then transferring 
into a HPLC vial. The sample was stored at -20oC until LC-MS-MS analysis. Target 
compounds were separated by LC-20A prominence (Shimadzu, Kyoto, Japan) 
high-performance liquid chromatography (HPLC) equipped with a separation column 
(Hypersil GOLDTM aQ, 100 mm2.1 mm, internal diameter 1.9 µm particle size). 
The mobile phase A was water and phase B was methanol. Table S3 (see SI) shows 
the HPLC gradient program. The mobile phase flow rate was set at 0.30 mL/min, and 
the column temperature was set at 30oC. The total run time for each injection was 12 
min and the injection volume were 20 µL. The target compounds were analysed using 
LC-ESI-MS/MS. ESI-MS/MS was performed at unit mass resolution in multiple 
reaction monitoring (MRM) under positive ion mode with the following parameters: 
source temperature (TEM) 450oC, ion spray voltage (IS) 3000 V, sheath gas pressure, 
40 psi. Optimization of compound-dependent MS/MS parameters was performed with 
steroid hormone standards via direct injection into the mass spectrometer using a 
syringe pump at a flow rate of 10 µL/min. Optimal settings for compound-dependent 
MS/MS parameters are shown in Table S4 (see SI). Two quality control samples and 
two sets of standards were analysed together with unknown samples in each analytical 
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batch (see SI Table S5). 
2.6. Statistical analysis 
We performed data analysis using SPSS statistical software (SPSS Inc.). The 
measured continuous variables of gene expression, carboxylesterase activity, phthalate 
hydrolysis ratio and steroid hormone levels were presented as mean with their 
standard errors of mean (mean ± SEM). Data were subjected to analysis by one-way 
ANOVA followed by Tukey’s multiple comparison testing to identify significant 
differences between groups when ≥3 groups were calculated. For all the tests, 
p-values <0.05 were considered as significant criteria. 
 
3. Results 
3.1. Hydrolysis metabolism associated with phthalates endocrine disrupting 
effects 
Hydrolytic activity of MLTC-1 cells towards phthalate diesters were examined 
(Figure 1A). The hydrolytic activity of MLTC-1 cells varied depending on the 
phthalate structure; relatively weak hydrolytic activity was observed towards 
phthalates having longer or bulky alkyl side chains on the alcohol ester moiety, while 
DBzP with two bulky benzyl chains cannot be hydrolysed into MBzP in MLTC-1 
cells at any concentration. The hydrolysis metabolism ratio declined linearly with an 
increasing level of phthalate diesters exposure. MLTC-1 cells exposed to low-dose 
(0.1-1 μM) phthalate diesters (except DBzP), there was almost total hydrolysis to 
corresponding phthalate monoesters, while hardly any level was hydrolysed following 
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high-dose (100 μM) exposure. The endocrine disrupting potency and relevant 
steroidogenic pathway gene response between mixed phthalate diesters and 
monoesters were also investigated (Figure 1B-F, see SI Table S6). At low-dose 
exposure (0.1-10 μM), phthalate diesters and monoesters exhibited androgenic effects 
(stimulating the production of ASD, 17-OHP and testosterone). At high-dose exposure 
(100 μM), phthalate diesters exerted anti-androgenic effects (inhibiting the production 
of ASD, 17-OHP and testosterone) because of their incomplete hydrolysis, while 
phthalate monoesters still exhibited androgenic effects (stimulating the production of 
ASD). Meanwhile, steroidogenic pathway gene expression was involved in 
phthalates-induced endocrine disrupting effects but exhibited a less than obvious 
dose-response trend due to the mixture exposure (Figure 1B and C).       
3.2. Extracellular esterase-enhanced phthalate diesters’ hydrolysis and 
attenuation of their anti-androgenic effects 
In order to confirm the hypothesis that hydrolytic metabolism can attenuate 
phthalates diester’ anti-androgenic effects, external addition of esterase was conducted 
at 100 μM mixed dose, at which the anti-androgenic action for all three steroids was 
apparent (i.e., inhibited). With the 100 μM mixture exposure, extracellular esterase 
significantly elevates the hydrolysis of DMP (from 19.30% to 59.20%, p < 0.001), 
DEP (from 6.71% to 34.95%, p < 0.001) and DBP (from 6.14% to 64.75%, p < 0.001); 
the change was not significant for DEHP (from 1.61% to 1.74%, p = 0.92) while no 
change is observed for DBzP (Figure 2A). When extracellular esterase was added in 
the 100 μM diester mixture group, the diester anti-androgenic effects (i.e., decreased 
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production of 17-OHP, ASD and testosterone) is completely reversed to androgenic 
effects (i.e., stimulating production of 17-OHP, ASD and testosterone); the observed 
androgenic action is similar to the mode of action of phthalates monoester mixture 
(Figure 2B-E). All selected androgen synthesis pathway genes except 17β-HSD 
(responsible for the ultimate conversion of ASD into testosterone) were inhibited at 
100 μM mixture diester phthalate (CYP17α exhibiting greatest level of 
down-regulation) and suggests a total anti-androgenic effect on all steroids, while 
CYP17α, P450SCC and 3β-HSD gene expression are significantly increased with 
extracellular esterase co-exposure (Figure 2B, see SI Table S7). These data show that 
extracellular esterase significantly facilitates mixed diesters’ hydrolysis, then 
attenuates anti-androgenic effects via modification of the steroidogenesis pathway 
gene expression profile. When compared to mixture monoesters in 100 μM group, the 
down-regulation of SR-B1 and StAR in 100D+ (100 μM of phthalate diesters mixture 
plus carboxylic ester hydrolase) group relates the major diester residuals of DEHP and 
DBzP, which are hard to metabolize by extracellular esterase in cell lines (Figure 2B). 
3.3. Inhibited intracellular carboxylesterase associated with reduced hydrolysis 
and enhanced activity of diester phthalates 
In order to confirm phthalate diester hydrolysis-associated toxicological changes, 
carboxylesterase (Ces) intervention experiments were conducted. Ces2a is an enzyme 
coded by Ces that is regulated by nuclear orphan constitutive active receptor (CAR) 
and can catalyse intracellular phthalate diester hydrolysis. Ten μM mixture phthalate 
diesters were set because this exposure exhibits both the hydrolysis margin (Figure 
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1A) and apparent effects on steroids. The results show PK 11195 is a CAR antagonist 
and can consequently significantly inhibit CAR-regulated Ces2a expression and 
enzyme activity in MLTC-1 cells (Figure 3A-B, see SI Table S8). When MLTC-1 
cells are co-exposed with a mixture of phthalate diesters and PK 11195, DMP and 
DEP hydrolysis are significantly inhibited (Figure 3 C). Slight androgenic effects 
(Figure 1D-F and 3E-G) are observed in 10 μM phthalate diesters mixture treatment, 
while significant anti-androgenic effects are observed when the phthalate diesters 
mixture is co-exposed with PK 11195 groups (decreased production of testosterone, P 
< 0.05) (Figure 3 G). Meanwhile, steroidogenesis pathway gene 3β-HSD expression is 
significantly down-regulated in 10 μM phthalate diesters mixture groups following 
PK 11195 exposure (P < 0.05) (Figure 3D, see SI Table S8). The results show that PK 
11195 induced inhibition of hydrolysis has a greater effect on SR-B1 than other genes, 
which may then be transferred to down-stream genes such as StAR and 3β-HSD (see 
SI Table S8). 
3.4. Individual different endocrine disrupting effects of phthalate in MLTC-1 
In order to directly compare the different effects of phthalate monoester with 
diester and distinguish structure-dependent toxicities, individual phthalate exposure 
experiments were conducted (Figure 4). In low-dose (10 μM) experiments, the 
phthalate diesters of DEP, DBP, DBzP and DEHP and monoester phthalate MEHP 
tend to exert androgenic effects (i.e., increase production of ASD and 17-OHP); no 
significant effect was observed for other phthalates (Figure 4). In high-dose (100 μM) 
treatments, DMP but not MMP exhibits stimulation of ASD production, and DEP but 
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not MEP exhibits androgenic effects (induced production of 17-OHP, ASD and 
testosterone). DBP exhibits anti-androgenic effects (inhibits production of 17-OHP, 
ASD and testosterone), while MBP shows androgenic effects (stimulates synthesis of 
ASD and testosterone) at 100 μM doses. DBzP inhibits 17-OHP and testosterone 
secretion, while both DBzP and MBzP have stimulant effects on ASD production and 
MBzP-induced testosterone secretion; DEHP inhibits 17-OHP, while DEHP 
stimulates ASD and MEHP stimulates 17-OHP and testosterone. In summary, if any 
effect tendencies arise from diester DMP or DEP or monoester MBP, MBzP and 
MEHP at 10 to 100 μM, they are stimulating; for other phthalates the effects are 
inhibitory for 17-OHP and testosterone at 100 μM but stimulating for ASD at both 10 
and 100 μM doses. 
Following treatment with phthalate monoesters, genes are up-regulated or 
unchanged with the two pathway terminal genes exhibiting the highest fold-changes 
(see SI Table S9; the down-regulated CYP17α for 100 μM MBP is apparent but not 
significant when compared to the DMSO control). When treated with low-dose 
phthalate diesters, genes are up-regulated or unchanged in their expression but with a 
generally reduced alteration when compared to 10 μM monoester counterparts (see SI 
Table S9). The pathway initiation SR-B1 gene encodes an integral membrane protein 
scavenger receptor class B and leads the up-regulation of androgenic effects, which 
may initially be the response to the androgenic action of phthalates. When all three 
steroids are inhibited (100 μM diester mixture or DBP treatments), StAR, CYP17α and 
P450SCC are all down-regulated and CYP17α is minimally down-regulated. However, 
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while incomplete steroid inhibition (ASD stimulation but 17-OHP and testosterone 
inhibition following 100 μM DzBP or DEHP treatments) is associated with 
up-regulation of mitochondrial P450SCC but down-regulation of StAR and CYP17α 
(Figure 4, see SI Table S9), which are the two genes just up-stream and down-stream 
of P450SCC (Figure 5). All the data implies that CYP17α initiates the anti-androgenic 
effect in the investigated steroidogenesis pathway. 
 
4. Discussion 
We observed that both extracellular esterase and the CAR-regulated intracellular 
carboxylesterase can catalyse the hydrolysis of phthalate diesters, and that these 
processes are closely associated with their endocrine disrupting effects (Figure 5). 
Meanwhile, phthalate diesters’ hydrolysis and endocrine disrupting potency depends 
on their alkyl side-chain structure. DBP elicits hydrolysis-related steroidogenic 
modulation, in which the anti-androgenic effect of this diester reverses into an 
androgenic effect of monoester MBP at 100 μM. Monoesters and diesters exhibit 
apparently differing endocrine disrupting effects, and these results were tested in both 
the transcriptional alteration of androgen synthesis pathway genes and fold-changes in 
three steroids. Our work indicates that the hydrolysis of phthalate diesters into 
monoesters is generally an anti-androgenic reversal process. 
4.1 Phthalate diesters’ hydrolysis in MLTC-1 cells 
It is well-documented that phthalate diesters can be quickly hydrolysed into 
monoesters in mammals by some non-specific esterases and lipases in the intestines 
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and parenchyma. Some long-chain monoesters can be in further metabolized via 
β-oxidation and then formed the hydrophilic glucuronide conjugates, which are easily 
excreted in urine (Calafat et al. 2006; Frederiksen et al. 2007). Our in vitro tests show 
that the hydrolysis of phthalate diesters by extracellular esterase is side-chain 
structure specific. Like many other xenobiotics, intracellular metabolism of phthalate 
diesters can be regulated by CAR. Intracellularly, diesters can bind to CAR with a 
higher potency than monoesters (Zhang et al. 2015). Our observations are further 
supported by the fact that the binding activity affects down-stream carboxylesterases 
(Ces) activity. Ces can been found in various tissues, such as the small intestine, colon, 
kidney, liver, heart, brain and testis (Xu et al. 2002). It has been recognized to play an 
important role in biotransformation of ester- and amide-containing compounds for 
detoxification and/or activation of a variety of xenobiotics and pharmacologics (Satoh 
and Hosokawa 2006). A previous study suggests that mRNA expression of Ces in 
mouse liver, duodenum and lung tissues are regulated by intracellular CAR (Jones et 
al. 2013); we found Ces expression to be also regulated by CAR in MLTC-1 cells. 
In using the CAR regulation of Ces, we tested whether testicular MLTC-1 cells 
can hydrolyse phthalate diesters into monoesters. Similar to liver microsomes 
(Hanioka et al. 2012), MLTC-1 cells exhibit high activity towards short-chain 
phthalates (i.e., DMP, DEP and DBP), while activity towards DEHP is marginal. 
Surprisingly aromatic chain DBzP cannot be hydrolysed into MBzP in MLTC-1 cells 
at any exposure. Therefore, the hydrolysis of diesters by intracellular Ces are also 
alkyl chain specific. This may be due to the bulky side-chains of DEHP and DBzP 
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protecting their ester bonds, resulting in poor bioavailability. The molecular specific 
hydrolysis agrees with in vitro liver microsomes tests and an in vivo kinetics study 
(Hanioka et al. 2012; Harris et al. 2016). In addition, the hydrolysis rates to high-dose 
diesters (100 μM) are lower than to low-dose (10 μM), so it is suspected that the 
process is not inducible; this is inconsistent with this notion that CAR regulation is 
constitutive but inducible. 
4.2 Phthalate diesters and monoesters associated with distinct endocrine effects 
Regarding phthalate structures associated with endocrine disrupting activities, 
there remains controversy. Many phthalate diesters are implied to be less toxic 
towards testosterone generation than their monoester counterparts, e.g., DEHP and 
DBP versus MEHP and MBP (Clewell et al. 2010; Sjöberg et al. 1986). However, a 
previous study also reports that DBP is more toxic than MBP in its inhibition of 
placental steroids (Xu et al. 2016). Although all previous studies (Barlow et al. 2003; 
Clewell et al. 2010; Parks et al. 2000) support the notion of phthalates inducing 
endocrine disrupting activity in testicular cells, the present work uncovers the 
molecular specific differences between diesters and monoesters: diesters at low-dose 
(10 μM) can slightly induce progesterone, ASD and testosterone secretion, and these 
trends are similar to 100 μM monoesters. When the intracellular diesters’ hydrolysis is 
inhibited, testosterone secretion is significantly decreased (Figure 3). Therefore, 
monoesters or the hydrolysis of diesters to monoesters is associated with androgenic 
effects. While diesters exhibit an apparent anti-androgenic effect at high-dose (100 
μM) exposure levels, it is because the major components of these phthalates are 
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diesters rather than monoesters in the cells. The individual exposure experiments also 
confirmed that the high-dose diesters have more potency in inhibiting steroid 
hormone secretion than monoesters (Figure 4). Given the environmentally-relevant 
exposures dose, phthalate diesters can be quickly hydrolysed into monoesters forms in 
the human body by a more comprehensive set of hydrolytic enzymes than in vitro 
tests, their activity would be reversed from anti-androgenic to androgenic. 
4.3 Hydrolysis attenuates phthalate diesters’ anti-androgenic effects in MLTC-1 
cells 
Androgen biosynthesis in Leydig cells involves the conversion from cholesterol, 
via a series of intermediates, to the end-product, testosterone. The reactions are 
catalysed by enzymes of SR-B1, StAR, P450SCC, Cyp17α, 3β-HSD and 17β-HSD 
(Ha et al. 2016) (Figure 5). Extracellular hydrolysis of phthalates diesters to 
monoesters can attenuate their apparently anti-androgenic effects both at gene 
transcriptional and metabolic levels. Impacts on all investigated steroidogenic genes 
were partly to completely reduced, and the production of 17-OHP and testosterone 
recovered whilst for ASD, there is an increase in comparison to the control (Figure 2). 
In human and rodent steroidogenic tissues, SR-B1 transports the cholesteryl esters 
into cells which is subsequently converted into pregnenolone by P450SCC in the 
inner mitochondrial membrane and, finally into progesterone via Cyp17α and 3β-HSD 
catalysis (Azhar and Reaven 2002). Most notable observations are the initial 
up-/down-regulation of SR-B1, which may be mostly responsible for the distinct 
modes of endocrine disrupting effects between phthalate diesters and monoesters 
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(Figure 4). The decrease in testosterone with SR-B1 and StAR gene expression 
post-exposure of rats and mouse to phthalates has been reported (Aydoğan and Barlas 
2015; Barlow et al. 2003; Wang et al. 2017). We propose that phthalate monoesters 
have more potential than their diester counterparts to initiate SR-B1 up-regulation for 
steroidogenesis; its inhibition would be associated with the down-regulation of 
Cyp17α and StAR, which are the down- and up-stream genes of the mitochondrial 
P450SCC. SR-B1 lead the up-regulation of all steroidogenesis genes such as 
P450SCC and Cyp17α and their expression together with increased ASD may imply 
the androgenic responses to monoesters’ exposure or diesters’ hydrolysis (Figure 4). 
While high-dose diesters (Figure 1) or the inhibition of their hydrolysis (Figure 3, 5) 
would further trigger downstream gene inhibition, i.e., P450SCC, Cyp17α, 3β-HSD. 
Interestingly, in response to low- to high-dose stimulation, Cyp17α expression altered 
dramatically and led to down-regulated gene expression, which may imply a complex 
the steroidogenic regulation. CYP17α is at a critical crossroad point in the pathways 
of steroid hormone biosynthesis (Gilep et al., 2011), and the enzymes of P450SCC 
and StAR are considered as rate-limiting in the steroid hormone synthesis pathway 
(Hasegawa et al., 2000, Miller, 1998). This information may also imply Cyp17α 
initiates down-regulation of steroidogenesis via its feedback to P450SCC and StAR, in 
which inhibited StAR may initially respond to down-regulated Cyp17α, with steroids 
partly decreased (examples are 100 μM DBzP and DEHP). Then P450SCC is 
subsequently inhibited and steroids are completely inhibited (e.g., 100 μM DBP). The 
mitochondrial-related backward regulation needs to be tested in further study. 
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Structure-dependent activity of phthalates has also been documented for other 
steroidogenic enzymes, such as inhibition of 17β-hydroxysteroid dehydrogenase 3 
(Yuan et al. 2012), 11β-hydroxysteroid dehydrogenase 2 (Zhao et al. 2010) and 
3β-hydroxysteroid dehydrogenase 1 CYP19A1(Xu et al. 2016). Our results indicate 
that diesters have more potency on steroidogenic gene expression, which is consistent 
with previous reports that diesters are inhibitors of CYP19A1 and CYP2B, while 
monoesters have no or little inhibition (Ozaki et al. 2016; Xu et al. 2016). The diesters 
and monoesters appear to exert different effects on the activity of human hormone 
receptors (AR and ER). The phthalates either stimulated or inhibited ERα and ERβ 
activity and inhibited AR activity, whereas the phthalate metabolites had no impact 
(Engel et al., 2017). Similar results also found in CAR-binding activities studies, due 
to phthalate monoester having only one side-chain to interact with the CAR active 
pocket, their binding activities are lower than those of their corresponding phthalate 
diesters (Zhang et al., 2015). Interestingly, the androgenic potency of phthalate 
diesters are found to increase with increasing carbon number of the linear alkyl chains 
from DMP to DBP, while anti-androgenic potency decreases from DBP to long/bulky 
DBzP and DEHP (Figure 4). The U-shaped endocrine disrupting effects of phthalate 
are in good agreement with the conformations of the phthalates upon binding to 
constitutive androstane receptor (Zhang et al. 2015). 
Conclusion 
The present study shows that phthalate diesters have side-chains structurally 
dependent on hydrolysis and steroidogenic effects in MLTC-1 Leydig cells. The 
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results indicate that DBP seems to elicit hydrolysis-related steroidogenesis 
modulation, in which the complete anti-androgenic effect of diester DBP reverses into 
a androgenic effect when it is hydrolysed into monoester MBP at 100 μM in Leydig 
cells. When compared to DBP, the anti-androgenic potency of DBzP and DEHP may 
be lower; the generation of androgens cannot be completely inhibited (ASD is 
stimulated) by DBzP and DEHP in Leydig cells even when treated with 100 μM, but 
the down-regulation tendency has been observed. DEP and DMP and all the 
investigated monoester phthalates only exhibit androgenic effects at the treatment 
dose ranges. Considering the ready metabolism of the investigated phthalate diesters 
in the human body, the observed toxicology improves our understanding of the 
environmentally-relevant phthalates’ reproduction risk in adult males. 
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Figure Legends 
 
Figure 1. Phthalates ester bonds associated with phthalates endocrine disruption. 
Phthalate diesters metabolism profile with mixture exposure in MLTC-1 cell (A), 
steroidogenesis pathway gene expression (B-C) and steroid hormones (17-OHP, ASD 
and testosterone) secretion response to diesters or monoesters mixed exposure (D-E).  
M: equimolar phthalate monoester mixtures (MMP, MEP, MBP, MBzP or MEHP in 
mixture) and D: equimolar phthalate diester mixtures (DMP, DEP, DBP, DBzP or 
DEHP in mixture). 
Data presented as Mean ± SEM is derived from three independent experiments. Heat 
maps showing changes in gene expression for steroidogenesis pathway gene after 
phthalate exposure, red colour represents up-regulation and green colour represents 
down-regulation. Asterisks indicate statistically significant differences, *p < 0.05 and 
**p < 0.01 in comparison to the vehicle. 
 
 
 
 
Figure 2. The extracellular esterase enhances phthalate diesters’ hydrolysis and 
attenuates their anti-androgenic effects. 
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The extracellular esterase facilitated phthalate diesters hydrolysis (A) can attenuate 
their anti-androgenic effects by altering the steroidogenesis pathway gene expression 
(B) and reversing androgen secretions (C-E) in the MLTC-1 cells. 
100 M: 100 μM of equimolar phthalate monoester mixtures (MMP, MEP, MBP, 
MBzP or MEHP in mixture); 100D: 100 μM of equimolar phthalate diester mixtures 
(DMP, DEP, DBP, DBzP or DEHP in mixture); 100D+: the addition of esterase in 
culture matrix to 100D group to facilitate phthalate diester hydrolysis. 
Data presented as mean ± SEM of the three independent experiments. Heat maps 
showing changes in gene expression for steroidogenesis pathway gene after phthalate 
exposure, red colour represents up-regulation and green colour represents 
down-regulation. Asterisks indicate statistically significant differences, *p < 0.05 and 
**p < 0.01. 
 
 
 
 
Figure 3. Inhibited intracellular carboxylesterase associated with reduced 
hydrolysis and enhanced activity of phthalate diesters. 
PK 11195 inhibits intracellular carboxylesterase gene expression (A) and enzyme 
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activity (B) then reduced diesters hydrolysis (C) and decreased steroidogenesis 
pathway genes expression (D) and androgen secretion (E-G). 
10D: 10 μM of equimolar DMP, DEP, DBP, DEHP and DBzP mixture, respectively. 
PK 11195: 5 μM 
1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide, 
10D+PK 11195: 10 μM phthalate diesters mixture plus with 5 μM PK 11195. 
Data are presented as Mean ± SEM of three independent experiments. Heat maps 
showing changes in gene expression for steroidogenesis pathway gene after phthalate 
exposure, red colour represents up-regulation and green colour represents 
down-regulation. Asterisks indicate statistically significant differences, *p <0.05 and 
**p <0.01. 
 
 
 
Figure 4. Different endocrine disrupting effects between phthalate diesters (A-D) 
and monoesters (E-H) individual exposure. 
Data are presented as Mean ± SEM of three independent experiments. Heat maps 
showing changes in gene expression for steroidogenesis pathway gene after phthalate 
exposure, red colour represents up-regulation and green colour represents 
down-regulation. Compared with DMSO vehicle group, asterisks indicate statistically 
significant differences, *p <0.05 and **p <0.01. 
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Figure 5. Phthalate hydrolysis metabolism associated with steroidogenesis effects 
in MLTC-1 Leydig cells. 
 
 AC
CE
PT
ED
 M
AN
US
CR
IPT
